Akoya to Participate at Three Upcoming Investor Conferences
Get Alerts AKYA Hot Sheet
Join SI Premium – FREE
MARLBOROUGH, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in three upcoming investor conferences.
- Stephens Annual Investment Conference | NASH 2023
Fireside Chat on Wednesday, November 15th at 11:00 AM CT
Nashville, TN
- Canaccord Genuity 2023 MedTech, Diagnostics and Digital Health & Services Forum
Fireside Chat on Thursday, November 16th at 2:30 PM ET
New York, NY
- Piper Sandler 35th Annual Healthcare Conference
Fireside Chat on Thursday, November 30th at 11:30 AM ET
New York, NY
A live and archived webcast of the events will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.
Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
[email protected]
Media Contact:
Christine Quern
(617) 650-8497
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Inflection Point Acquisition Corp. V and GOWell Energy Technology Announce Effectiveness of Registration Statement for Proposed Business Combination
- Firm Capital Property Trust Reports Strong Q2/2026 Results
- Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share